Skip to main content
ARTIVION, INC. logo

ARTIVION, INC. — Investor Relations & Filings

Ticker · AORT ISIN · US2289031005 LEI · 549300YTKV8DMSMG6K81 US Manufacturing
Open in API
Filings indexed 1,531 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country US United States of America
Listing US AORT

About ARTIVION, INC.

https://artivion.com/

Artivion, Inc. is a medical device company focused on developing, manufacturing, and distributing solutions for cardiac and vascular surgery. The company has an intentional focus on creating technologies to treat diseases of the aorta. In collaboration with surgeons, Artivion develops products designed to address complex surgical challenges. Its portfolio includes a range of aortic-centric technologies, such as heart valve solutions, implantable human tissues (allografts), surgical sealants, and various stent grafts for the aortic arch, thoracoabdominal, abdominal, and peripheral aorta. The company's purpose is to provide simple, elegant solutions that improve surgical outcomes for patients with aortic diseases.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 85% confidence The document is a Form SD (Specialized Disclosure Report) filed under SEC rules, providing a Conflict Minerals Report as an exhibit. It is a compliance/regulatory disclosure filing rather than an annual or quarterly report, management discussion, proxy, or other specific category. This matches the fallback category for general regulatory filings.
2026-05-21 English
8-K
Regulatory Filings Classification · 85% confidence The document is a SEC Form 8-K “Current Report” under the Exchange Act, consisting of Regulation FD disclosure, completion of an acquisition (Other Events), and exhibit listings. It is a direct regulatory filing and does not contain substantive financial statements (so not IR or 10-K), nor is it a proxy/merger proxy (so not MA or TAR), director share dealings, or other more specific categories. Therefore it falls into the fallback category “Regulatory Filings (RNS).”
2026-05-18 English
8-K
Regulatory Filings
2026-05-15 English
10-Q - ARTIVION, INC. (0000784199) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-08 English
8-K
M&A Activity Classification · 92% confidence The document is a SEC Form 8-K “Current Report” that discloses (Item 1.01) the entry into and exercise of a Securities Purchase Option Agreement to acquire Endospan’s securities/assets, and (Item 2.02) the related financial results press release. This constitutes an announcement of M&A activity rather than an actual annual or interim financial report, earnings release, or governance update. Therefore, it fits squarely into the M&A Activity category (TAR).
2026-05-07 English
ARS - ARTIVION, INC. (0000784199) (Filer)
Annual Report
2026-04-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.